Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Mindfulness for Cognition in Early-stage Alzheimer's Disease

VA Boston Healthcare System · NCT06792877

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 50–100 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
100
US sites recruiting
1
Study start
January 23, 2025
Record last updated
January 27, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this clinical trial is to learn if mindfulness meditation can improve outcomes in older adults with and without cognitive impairment. The main questions it aims to answer are:

  • How does mindfulness impact thinking and memory?
  • How does mindfulness influence brain function and structure?
  • How does mindfulness affect daily function and quality of life?

Researchers will compare all outcomes to one other groups. In one group, individuals will participate in a mindfulness class intervention; in the other group, individuals will not engage in any active interventions immediately, but will be placed on a waitlist for the mindfulness intervention. Researchers will compare all outcomes between the groups groups to determine whether the mindfulness interventions leads to greater improvement compared to no intervention (waitlist group).

Participants will

  • Be randomly assigned to participate in the mindfulness intervention, or no immediate intervention (waitlist)
  • Complete paper-and-pencil cognitive testing, surveys, computerized tasks, and neuroimaging measures (EEG and MRI) before and after the intervention

Outcomes will be assess at baseline, 2 months, 4 months and 6 months.

Being studied: Mindfulness Intervention; Waitlist then mindfulness

Conditions: Mild Cognitive Impairment (MCI); Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease; TBI (Traumatic Brain Injury); Aging; Healthy Elderly; Alzheimer&Amp;Amp;#39;s Dementia (AD)

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Healthy older adults will show cognitive performance within 1.0 SD for age \& education adjusted norms on a neuropsychological test battery
  • Mild cognitive impairment (MCI) participants will show performance on delayed recall or one more or more other cognitive domains worse than 1.5 SD for age \& education adjusted norms, an MMSE score between 25-30, and a MoCA score between 20-30.

Exclusion Criteria

  • Participants without a computer, smart phone and internet access will be excluded
  • If they cannot understand the informed consent form or have moderate dementia.
  • Mood disorders (e.g., PTSD, depression, anxiety) or alcohol and drug use that either interferes with day-to-day life or required hospitalization within the past 5 years
  • Cerebrovascular disease
  • Any medical condition whose severity could significantly impair cognition (e.g., stroke, frontotermporal dementia, Parkinson's disease) are exclusionary

Recruiting US locations

  • VA Boston Healthcare System - Jamaica Plain Campus

    Boston, MA 02130

    Site contact: Kathy Xie, PhD · 8573645429 · ctcnbrainlab@gmail.com

Study contacts (from the official record)

  • Katherine W Turk, MD · 8573645429 · ctcnbrainlab@gmail.com
  • Kathy Y Xie, PhD · 8572300905 · ctcnbrainlab@gmail.com
All neurology studies in Massachusetts →
Mindfulness for Cognition in Early-stage Alzheimer's Disease (NCT06792877) | Bored Studies